Privia Health Group (NASDAQ:PRVA) Announces Quarterly Earnings Results, Beats Expectations By $0.11 EPS

Key Points

• Privia Health beat Q1 expectations: The company reported EPS of $0.19, well above the $0.08 consensus, while revenue came in at $603.85 million versus expectations of $560.99 million. Revenue also rose 25.8% year over year.
• Management sees continued growth ahead: Privia reaffirmed its 2026 guidance and raised only its attributed-lives outlook, signaling confidence in its growth trajectory. The company also highlighted a revenue outlook of $2.4 billion to $2.5 billion for 2026.
• Operational momentum and balance sheet remain strong: Provider count and attributed lives grew sharply, helping drive higher collections and EBITDA expansion. Privia ended the quarter with $419.5 million in cash and no debt, leaving room for organic growth and selective M&A.

Privia Health Group (NASDAQ:PRVA - Get Free Report) issued its quarterly earnings results on Thursday. The company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.08 by $0.11, FiscalAI reports. Privia Health Group had a net margin of 0.97% and a return on equity of 2.81%. The firm had revenue of $603.85 million during the quarter, compared to analysts' expectations of $560.99 million. During the same quarter in the prior year, the business earned $0.22 EPS. Privia Health Group's quarterly revenue was up 25.8% compared to the same quarter last year.

Here are the key takeaways from Privia Health Group's conference call:

• Provider and attribution growth: Implemented providers reached 5,535 (+13.6% YoY) and attributed lives hit 1.6M (+26.5% YoY), driving practice collections up 14.6% to $914.8M and providing visible revenue runway for 2026.
• Profitability expansion: Adjusted EBITDA rose 36.3% to $36.7M with EBITDA representing 28.5% of care margin (up 290 bps), and management expects ~20% EBITDA growth at the midpoint of guidance with ~80% conversion to free cash flow.
• Strong balance sheet and reiterated guidance: Ended Q1 with $419.5M cash and no debt, maintained full-year 2026 guidance (raising only attributed-lives range), and signaled capacity to fund organic growth and disciplined M&A.
• M&A and integration progress: The Evolent ACO assets are reported ahead of integration schedule, management says the business-development pipeline is robust and will be used to expand Privia’s multi-state footprint.
• Technology and AI focus: New CTO hire and a push to deploy generative AI across enterprise, care-center, and care-delivery workflows are expected to boost productivity and help push margins toward the high end of long-term targets.

Privia Health Group Trading Down 3.7%

Shares of Privia Health Group stock traded down $0.90 on Friday, reaching $23.10. 1,080,445 shares of the stock were exchanged, compared to its average volume of 972,100. The firm has a market capitalization of $2.90 billion, a PE ratio of 144.35, a PEG ratio of 1.50 and a beta of 0.96. Privia Health Group has a 1-year low of $18.77 and a 1-year high of $26.51. The business has a fifty day moving average price of $22.73 and a two-hundred day moving average price of $23.34.

Trending Headlines about Privia Health Group

Here are the key news stories impacting Privia Health Group this week:

• Positive Sentiment: Privia Health reported first-quarter results that beat revenue expectations, with sales of $603.85 million versus the $560.99 million estimate, and EPS of $0.19 versus $0.08 expected. The company also said revenue rose 25.8% year over year, and it reiterated full-year 2026 guidance. Article Title
• Positive Sentiment: The company’s updated 2026 outlook calls for revenue of $2.4 billion to $2.5 billion, which is in line with or slightly above market expectations and supports the case for continued growth. Article Title
• Neutral Sentiment: Investors are also parsing the Q1 2026 earnings call transcript and related earnings coverage for management commentary on margins, utilization trends, and the path to hitting full-year targets. Article Title
• Negative Sentiment: Two insider-selling reports may be weighing on sentiment: the CFO sold about $179,690 of stock and a director sold about $427,229 of stock, which can signal caution even when fundamentals are improving. Article Title Article Title

Insider Activity at Privia Health Group

In related news, Director Matthew Shawn Morris sold 1,017 shares of Privia Health Group stock in a transaction that occurred on Monday, May 4th. The stock was sold at an average price of $24.96, for a total value of $25,384.32. Following the sale, the director directly owned 68,188 shares in the company, valued at $1,701,972.48. The trade was a 1.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Mountcastle sold 1,206 shares of the stock in a transaction on Monday, May 4th. The stock was sold at an average price of $25.00, for a total value of $30,150.00. Following the completion of the transaction, the chief financial officer owned 214,847 shares of the company's stock, valued at $5,371,175. The trade was a 0.56% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 274,255 shares of company stock worth $6,299,092 over the last 90 days. Company insiders own 5.70% of the company's stock.

Institutional Trading of Privia Health Group

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Global Retirement Partners LLC grew its position in Privia Health Group by 579.8% during the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company's stock worth $38,000 after buying an additional 1,351 shares during the period. Canada Pension Plan Investment Board boosted its stake in shares of Privia Health Group by 48.0% during the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company's stock worth $85,000 after acquiring an additional 1,200 shares in the last quarter. Kestra Advisory Services LLC purchased a new stake in shares of Privia Health Group during the 4th quarter worth approximately $93,000. Raymond James Financial Inc. acquired a new stake in shares of Privia Health Group in the 2nd quarter worth approximately $113,000. Finally, Acadian Asset Management LLC purchased a new position in Privia Health Group in the 1st quarter valued at approximately $154,000. Institutional investors and hedge funds own 94.48% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on PRVA. Evercore set a $26.00 target price on shares of Privia Health Group in a research note on Wednesday, April 8th. Royal Bank Of Canada began coverage on Privia Health Group in a research report on Friday, January 9th. They issued an "outperform" rating and a $31.00 price target on the stock. Citigroup decreased their price objective on Privia Health Group from $34.00 to $32.00 and set a "buy" rating for the company in a research report on Tuesday, March 3rd. Truist Financial lifted their target price on Privia Health Group from $31.00 to $33.00 and gave the company a "buy" rating in a research note on Monday, March 2nd. Finally, Piper Sandler reissued an "overweight" rating and issued a $36.00 target price on shares of Privia Health Group in a report on Thursday, February 26th. Eleven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Privia Health Group has an average rating of "Moderate Buy" and an average target price of $31.23.

Privia Health Group Company Profile

Privia Health Group NASDAQ: PRVA is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.